SCHEMBL21030698

SCHEMBL21030698

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4c5ccccc5nc5c4sc4ccccc45)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ATM Q13315 1/20 0.42
TNKS O95271 2/20 0.40
TNKS2 Q9H2K2 2/20 0.40
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
SCD O00767 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.37
LIMK1 P53667 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PDE5A O76074 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
HCRTR1 O43613 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031515 0.99 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21030688 0.99 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21032087 0.99 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21030686 0.99 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21030638 0.93 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21030945 0.93 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21030946 0.93 MEN1 (0.40) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21031028 0.92 LIMK1 (0.38) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21031192 0.92 MEN1 (0.43) MEN1KMT2AATMTNKSTNKS2
SCHEMBL21032090 0.92 MEN1 (0.43) MEN1KMT2AATMTNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-20230126868-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 US disclosed
US-20230126868-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ATM 3827/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885ATM 3827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.